Navigation Links
Moleac Launches NeuroAid10(TM) in the United States
Date:3/6/2008

Supplement to help support Neurological Function Now Available in the US

SINGAPORE, March 6 /Xinhua-PRNewswire/ -- Singapore-based Moleac today launched a new product called NeuroAid10(TM) in the US market to support patients' neurological functions. NeuroAid10(TM) is derived from NeuroAid(TM) and is a combination of ten all-natural ingredients. Moleac is a global biopharmaceutical company that brings together the best of Asian and Western medicine.

Since its launch in 2000, NeuroAid(TM) has been used by 200,000 stroke survivors every year in Asia alone. In addition, a growing number of Americans have already started using NeuroAid(TM) regularly with positive results on their neurological functions.

The clinical data obtained with NeuroAid(TM) on recovery several months after a stroke has triggered large interest in the neurology community. In October 2007, enrollment began for a multi-center, double-blind, placebo- controlled, randomized trial. This aims to evaluate the efficacy of NeuroAid(TM) in reducing neurological deficit and improving independence in patients in rehabilitation, with treatment starting within 48 hours of a stroke. "The CHIMES Stroke Study is ground-breaking for the medical industry as the largest clinical trial on stroke recovery and the first time any TCM product has been assessed on this wide a scale outside China," said Professor Geoffrey Donnan, President World Stroke Organization, who chairs the study data and safety monitoring committee.

NeuroAid(TM) is already commonly used in several countries. "As we received an increasing number of requests from individuals in US to make NeuroAid(TM) available locally, we have engineered a new formulation which is marketed as Neuroaid10TMin the US, a dietary supplement to help support the neurological functions. NeuroAid10(TM) is an herbal natural dietary supplement, containing the 10 main ingredients of NeuroAid(TM), carefully selected and manufactured with the same stringent process as NeuroAid(TM)," said David Picard, CEO Moleac.

NeuroAid10(TM) is marketed in the US as an herbal dietary supplement with the indication to help support neurological functions.

Neurological functions involve the brain and the nervous system. The nervous system connects the entire human body, relaying information back and forth between the brain and the muscles, skin and key organs, allowing actions such as movement, and sensations such as pain. The smooth transmission of information between the brain and the rest of the body is therefore essential for daily activities such as walking, speaking or thinking, and can only occur when neurological functions are healthy and strong.

Ruth Lycke, a stroke survivor and the author of "Hope, Help and Healing", said, "I am thrilled to see NeuroAid10(TM) now available locally after having benefited myself from the treatment in China."

NeuroAid10(TM) does not contain any of the animal based ingredients of NeuroAid(TM) which were considered as secondary in the original formulation. "We will work with health authorities around the world to make NeuroAid(TM) available in international markets over the coming years," said Picard.

Moleac has now established a robust distribution system in the US with Suresource. The product can be purchased at http://www.neuroaid10.com or at http://www.amazon.com .

About NeuroAid10(TM)

NeuroAid10(TM) is a Dietary Supplement that provides support for neurological functions. It is a combination of ten all ingredients from the Chinese medicinal pharmacopoeia, formulated according to international Good Manufacturing Practice (GMP) standards. It is marketed internationally by Moleac. For more information visit http://www.neuroaid10.com or by calling +1-800-421-1223.

About Moleac

Moleac is a biopharmaceutical company based in the Republic of Singapore;. Moleac identifies promising medicines and develops them for broad distribution. Focusing on patients' greatest needs and specific unmet medical needs, Moleac drives research, development and registration for a pipeline of drugs and devices in various stages of development.

DISCLOSURE NOTICE: The information contained in this release is as of March 20,2008. Moleac assumes no obligation to update any forward-looking statements contained in this release as the result of new information or future events or developments. This release contains forward-looking information about the potential benefits of NeuroAid(TM) and NeuroAid10(TM) that involves substantial risks and uncertainties.

Contact:

Moleac

Tel: +65-6478-9431 or +1-203-404-8258

Email: news@moleac.net


'/>"/>
SOURCE Moleac
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
2. Novozymes Launches Enzyme to Reduce Acrylamide in Food
3. Enova Medical Launches Exos Corporation
4. Elekta Launches New Linear Accelerator at 2007 ESTRO to Expand Cancer Treatment Availability
5. Signalifes Dr. Harmison Launches Award-Winning Ambulatory Heart Monitor
6. ThirdBiotech Networking Group Launches
7. BioReliance Launches Next-Generation Genotoxicity Screening Service
8. Midwest Research Institute Launches Center for Biological Safety and Security (CBS2)
9. BioReliance Corporation Launches iNet(TM) for Online Results Tracking of Biological Safety Tests
10. Kingfisher Healthcare Launches Breakthrough Product in Europe
11. Spectral partner launches EAA(TM) Rapid Sepsis Diagnostic in Germany
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... 2016 , ... Researchers at the Universita Politecnica delle Marche in Ancona combed ... pleural mesothelioma. Their findings are the subject of a new article on the Surviving ... signposts in the blood, lung fluid or tissue of mesothelioma patients that can help ...
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
(Date:6/23/2016)... HOUSTON , June 23, 2016 ... agreement with the Cy-Fair Sports Association to serve ... of the agreement, Houston Methodist Willowbrook will provide ... education and connectivity with association coaches, volunteers, athletes ... partner with the Cy-Fair Sports Association and to ...
(Date:6/23/2016)...  The Biodesign Challenge (BDC), a university competition that ... living systems and biotechnology, announced its winning teams at ... New York City . The teams, ... at MoMA,s Celeste Bartos Theater during the daylong summit. ... curator of architecture and design, and Suzanne Lee ...
Breaking Biology Technology:
(Date:4/26/2016)... 27, 2016 Research and ... Biometrics Market 2016-2020"  report to their offering.  , ... The analysts forecast the global multimodal biometrics ... during the period 2016-2020.  Multimodal biometrics ... such as the healthcare, BFSI, transportation, automotive, and ...
(Date:4/14/2016)... 14, 2016 BioCatch ™, ... today announced the appointment of Eyal Goldwerger ... Goldwerger,s leadership appointment comes at a time ... the deployment of its platform at several of the ... which discerns unique cognitive and physiological factors, is a ...
(Date:3/29/2016)... 29, 2016 LegacyXChange, Inc. (OTC: ... and SelectaDNA/CSI Protect are pleased to announce our successful ... a variety of writing instruments, ensuring athletes signatures against ... collectibles from athletes on LegacyXChange will be assured of ... DNA. Bill Bollander , CEO states, ...
Breaking Biology News(10 mins):